Xenon Pharmaceuticals XENE Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's total current assets?
- Xenon Pharmaceuticals (XENE) reported total current assets of $1.11B in Q1 2026.
- How has Xenon Pharmaceuticals's total current assets changed year-over-year?
- Xenon Pharmaceuticals's total current assets increased by 95.7% year-over-year, from $565.54M to $1.11B.
- What is the long-term trend for Xenon Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's total current assets has grown at a 25.3% compound annual growth rate (CAGR), from $181.78M to $560.65M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.